News

Borqs Technologies Sees Major Financial Improvement in 2024

Borqs Technologies Sees Major Financial Improvement in 2024

Borqs Technologies Reports Remarkable Financial Turnaround

SANTA CLARA, Calif. — Borqs Technologies, Inc. (U.S. OTC: BRQSF), a prominent player in embedded software and IoT products, has unveiled its financial performance for the first half of 2024. The company's interim financial statements have been duly filed with relevant authorities, providing insights into its robust growth and strategic maneuvers.

Financial Achievements for Half-Year 2024

In the six months ending on June 30, 2024, Borqs Technologies posted impressive net revenues amounting to US$16.77 million, demonstrating an 11.9% increase from US$14.99 million recorded in the same timeframe last year. This success stems from the company’s strength across both software and hardware sectors, highlighting its efficient operational framework.

Growth in Key Financial Metrics

The company’s gross profit rose to US$3.39 million, compared to US$2.91 million in the earlier year. This reflects a growing gross margin of 20.2%, up from 19.4%. Borqs has adeptly navigated its operating expenses, which have dramatically decreased to US$7.08 million from US$12 million the previous year. Such a decrease is primarily attributed to lower general and administrative costs, emphasizing the company’s focus on operational efficiency.

A Profitable Shift in Operations

One of the most notable outcomes from Borqs Technologies' strategic initiatives is its remarkable recovery in net income. For the first half of 2024, it recorded a net income of US$15.02 million from operations, marking a significant turnaround from a net loss of US$28.80 million during the same period last year. This financial recovery is largely due to astute management decisions, including the sale of the company’s interests in its solar subsidiary, which provided much-needed capital.

Management's Insights on Future Growth

“Our H1 results highlight the significant progress we are making in executing our recently outlined capital structure revamp,” stated Pat Chan, Chairman & CEO of Borqs Technologies. “The strategic actions we implemented in the first half of this year position us for improved profitability and enhanced liquidity going forward. We are encouraged by the positive underlying trends that these results reflect.”

Understanding Borqs Technologies’ Vision

As a leader in the internet of things domain, Borqs is dedicated to creating customizable, scalable, and efficient Android-based platforms that redefine smart connected devices. Leveraging its solid relationships with strategic chipset partners, the company continues to enhance its software and intellectual property portfolio. Their agile approach allows Borqs to remain at the forefront of innovation in IoT solutions, aligning with market demands and customer needs.

The Future of IoT Solutions

Borqs Technologies continues to navigate the evolving landscape of technology, maintaining an edge through its Android licenses and diverse software libraries. The company is well-equipped to cater to both high-volume and customized low-volume production environments, reinforcing its position as a pivotal influencer in the IoT market.

Investor Relations and Contact

For those seeking more information on Borqs Technologies, the company encourages potential investors and interested parties to reach out for inquiries. The investor relations contact is available at IR@borqs.com for further engagement and information sharing.

Frequently Asked Questions

What were Borqs Technologies' net revenues for the first half of 2024?

Borqs Technologies reported net revenues of US$16.77 million for the first half of 2024.

How did the company improve its operating expenses?

Operating expenses decreased significantly, from US$12 million last year to US$7.08 million in the first half of 2024, primarily due to reductions in administrative costs.

What is the significance of the net income reported?

The company reported a net income of US$15.02 million, a major improvement from a net loss of US$28.80 million in the same period the previous year.

Who is the CEO of Borqs Technologies?

The CEO of Borqs Technologies is Pat Chan, who has expressed optimism about the company’s financial strategies and future growth potential.

How does Borqs Technologies differentiate itself in the IoT market?

Borqs focuses on providing customizable, scalable solutions through its innovative software products and strong partnerships within the chipset ecosystem.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Sandler Partners Unveils 2025 Superstar Trip Destination

Updated Category News Views 179

Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...

Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today

Updated Category News Views 309

Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...

Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban

Updated Category News Views 216

Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...

Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners

Updated Category News Views 275

BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...

Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week

Updated Category News Views 120

Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...

Continue Reading